Chronic Toxic Effects Following Adjuvant Anti–PD-1 Therapy for High-Risk Resected Melanoma
25/3/2021
0:00
17:39
Interview with Douglas B. Johnson, MD, author of Chronic Immune-Related Adverse Events Following Adjuvant Anti–PD-1 Therapy for High-risk Resected Melanoma
Altri episodi di "JAMA Oncology Author Interviews"
Non perdere nemmeno un episodio di “JAMA Oncology Author Interviews”. Iscriviti all'app gratuita GetPodcast.